Cytochrome P450 transcriptional enhancer nucleic acid molecule

Details Cytochrome P450 transcriptional enhancer nucleic acid molecule Cytochrome P450 transcriptional enhancer nucleic acid molecule

2006-01-10

2006-01-10

Goldberg, Jeanine A. (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091100, C435S091200, C435S325000, C435S320100, C536S023100

Reexamination Certificate

active

06984489

ABSTRACT:
An isolated nucleic acid molecule comprising a nucleotide sequence encoding a transcriptional enhancer of cytochrome P450 (P450) CYP3A4 production or expression is disclosed, as are uses of the nucleic acid molecule for screening compounds for xenobiotic induction of CYP3A4 expression in cells and animals.

REFERENCES:
patent: 5429948 (1995-07-01), Crespi et al.
patent: 644267 (1995-03-01), None
patent: WO 99/13106 (1999-03-01), None
patent: WO 99/35246 (1999-07-01), None
Ahern, H. Biochemical, reagent kits offer scientists good return on investment. The Scientist 9(15):20 (Jul. 1995).
Hamzeiy et al. “Mutation analysis of the human CYP3A4 gene 5′ regulatory region: population screening using non-radioactive SSCP.” Mutation Research. vol. 500, pp. 103-110, 2002.
Hashimoto, et al.,Eur. J. Biochem. 218:585-595 (1993).
Dogra, et al.,Clinical and Experimental Pharmacology and Physiology, 25:1-9 (Jan. 1998).
Kolars, et al.,Pharmacogenetics, 4:247-259 (1994).
Kovaleva, et al.,Biochem. Biophys. Res. Comm., 221:129-132 (1996).
Ogg, et al.,Eur. J. of Drug Metabolism and Pharmacokinetics, 22(4):331-313 (1997).
Hakkela, et al.,Crit. Rev. Toxical., 28(1):35-72 (Jan. 1998).
Yanagida et al.,Mol. Cell Biol., 10:1470-1475 (1990);DNA, 7:79-86 (1988).
J. M. Lehmann, et al., “The Human Orphan Nuclear Receptor PXR is Activated by Compounds that Regulate CYP3A4 Gene Expression and Cause Drug Interactions”,J. Clin. Invest., 102(5):1016-1023 (1998).
G. Betilsson, et al., “Identification of a Human Nuclear Receptor Defines a New Signaling Pathway forCYP3AInduction”,Proc. Nat'l Acad. Sci., USA, 95:12208-12213 (Oct. 1998).
Blumberg, et al., “SXR, a Novel Steroid and Xenobiotic Sensing Nuclear Receptor”,Genes&Dev., 12:3195-3205 (1998).
D.J. Mangelsdorf, et al., “The Nuclear Receptor Superfamily: The Second Decade”,Cell, 83:835-839 (Dec. 1995).
M. Baes, et al., “A New Orphan Member of the Nuclear Hormone Receptor Superfamily that Interacts with a Subset of Retinoic Acid Response Elements”,Mol. Cell Biol., 14:1544-1552 (Mar. 1994).
T.R. Rebbeck, et al., “Modification of the Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4”,J. Nat'l Cancer Inst., 90(16):1225-1229 (Aug. 1998).
C.A. Felix, et al., “Association ofCYP3A4Genotype with Treatment-Related Leukemia”,Proc. Nat'l Acad. Sci., USA, 95:13176-13181 (Oct. 1998).
Goodwin, et al.,Mol. Pharmocol., 56:1329-1339 (1999).

Affiliated with

Also associated with

Rating

Cytochrome P450 transcriptional enhancer nucleic acid molecule does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytochrome P450 transcriptional enhancer nucleic acid molecule, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytochrome P450 transcriptional enhancer nucleic acid molecule will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3557912